BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 14
- 13F valueReported value at the end of Q2 2026
- $206.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BLRX, Q2 2026
No superinvestor reported holding BLRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BioLineRx Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by BioLineRx Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in BioLineRx Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 30,911 | $95.8K | 0.00% | +30,911 | New |
| Renaissance Technologies LLC | 15,412 | $48.1K | 0.00% | +15,412 | New |
| Citadel Advisors LLC | 14,796 | $45.9K | 0.00% | +14,796 | New |
| Rhumbline Advisers | 2,478 | $7.68K | 0.00% | +125+5.3% | Added |
| Wells Fargo & Company | 2,000 | $6.24K | 0.00% | +250+14.3% | Added |
| BNP Paribas Arbitrage, SA | 500 | $1.55K | 0.00% | −1,300−72.2% | Reduced |
| Nemes Rush Group LLC | 250 | $780 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 101 | $315 | 0.00% | −428−80.9% | Reduced |
| GWM Advisors LLC | 82 | $256 | 0.00% | −25−23.4% | Reduced |
| Advisor Group Holdings, Inc. | 26 | $81 | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of BLRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioLineRx Ltd..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Highbridge Capital Management LLC | 13G | 7.20%173.0M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |